Many U.S. Seniors Do Not Intend to Vaccinate Against RSV
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 13, 2024 -- Many U.S. seniors do not intend to vaccinate against respiratory syncytial virus (RSV) in the 2023 to 2024 season, according to a study published online Jan. 19 in Health Affairs Scholar.
Simon F. Haeder, Ph.D., from Texas A&M University in College Station, queried Americans older than age 60 years about their RSV vaccination status and their intention to vaccinate this fall and winter in a large national survey.
Haeder found that 9 percent of those surveyed had already been vaccinated; 42 percent of those who were unvaccinated indicated their intent to vaccinate. The likelihood of seeking out vaccinations was increased for those with higher levels of concern for the disease, higher levels of self-assessed risk, and higher levels of trust in health institutions; those believing the vaccines were safe and important; and men. Lack of necessity, concerns about side effects and safety, and a lack of information were primary reasons for vaccine-hesitant respondents.
"Policymakers ought to respond to these findings by implementing evidence-based policies that increase vaccination rates in the immediate as well as long-term future," Haeder writes. "These efforts should focus on highlighting the safety and importance of vaccines as well as the potential risks to individuals who fail to vaccinate."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care
TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.